Rintaro Yoshida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rintaro Yoshida has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Eiji Kusumoto
National Hospital Organization Kyushu Medical Center - Department of Gastroenterlogical Surgery
1 shared publication- Eiji Oki
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
1 shared publication - Eriko Tokunaga
Department of Breast Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan
1 shared publication - Fumihiro Shoji
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
1 shared publication Hideaki Uchiyama
Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
1 shared publicationHiroshi Matsuura
Department of Surgery, Saiseikai Fukuoka General Hospital, Fukuoka, Japan
1 shared publication
Latest Publications
- 16 November 2021
- Published by S. Karger AG in Digestive Surgery
- Vol. 38 (5-6) , 361-367
Impact of a 7.5-Fr Pancreatic Stent for Preventing Pancreatic Fistula after Pancreaticoduodenectomy
Introduction: Pancreatic duct stents are widely used to reduce the incidence of postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD); however, small stents may cause adverse effects, such as occlusion. Recently, we have tried placing a 7.5-Fr pancreatic duct stent to achieve more effective exocrine output from the pancreas; however, the association between pancreatic duct stent size and POPF remains unknown. Methods: Sixty-five patients with soft pancreatic texture who underwent PD were retrospectively analyzed. After dividing the pancreas, a pancreatic duct stent (stent size 4.0 in 29 patients, 5.0 in 18, and 7.5 Fr in 18) was placed in the main pancreatic duct. Results: Twenty-five of 65 patients with soft pancreatic texture (38.5%) developed POPF. POPF became less frequent as the pancreatic duct stent size increased (p = 0.003). The factors associated with POPF development were a 7.5-Fr pancreatic duct stent (p = 0.005), 5.0-Fr pancreatic duct stent (p = 0.031), and male sex (p = 0.008). Pancreatic duct stent size and pancreatic duct diameter did not differ between the POPF and non-POPF groups. Discussion/Conclusions: In patients with a soft pancreas, the placement of a 7.5-Fr pancreatic duct stent may reduce the incidence of POPF.
- 16 November 2021
- Published by S. Karger AG in Digestive Surgery
- Vol. 38 (5-6) , 361-367
Impact of a 7.5-Fr Pancreatic Stent for Preventing Pancreatic Fistula after Pancreaticoduodenectomy
Introduction: Pancreatic duct stents are widely used to reduce the incidence of postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD); however, small stents may cause adverse effects, such as occlusion. Recently, we have tried placing a 7.5-Fr pancreatic duct stent to achieve more effective exocrine output from the pancreas; however, the association between pancreatic duct stent size and POPF remains unknown. Methods: Sixty-five patients with soft pancreatic texture who underwent PD were retrospectively analyzed. After dividing the pancreas, a pancreatic duct stent (stent size 4.0 in 29 patients, 5.0 in 18, and 7.5 Fr in 18) was placed in the main pancreatic duct. Results: Twenty-five of 65 patients with soft pancreatic texture (38.5%) developed POPF. POPF became less frequent as the pancreatic duct stent size increased (p = 0.003). The factors associated with POPF development were a 7.5-Fr pancreatic duct stent (p = 0.005), 5.0-Fr pancreatic duct stent (p = 0.031), and male sex (p = 0.008). Pancreatic duct stent size and pancreatic duct diameter did not differ between the POPF and non-POPF groups. Discussion/Conclusions: In patients with a soft pancreas, the placement of a 7.5-Fr pancreatic duct stent may reduce the incidence of POPF.
- Open Access
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Prediction of Hospital Mortality after Colorectal Perforation Surgery from Inflammation-Based Prognostic Scores
Background: Inflammation-based prognostic scores (IBPSs) have prognostic value in cancer or cardiovascular disease patients. This study evaluated the prognostic value of IBPSs in colorectal perforation patients. Methods: Data of 97 patients who underwent surgery for colorectal perforation were reviewed. We calculated various IBPSs, and analyzed the relationship between IBPS and hospital mortality due to colorectal perforation. Results: Multivariate analyses of hospital mortality revealed neutrophil-lymphocyte ratio (NLR) ( P =0.0021), C-reactive protein/albumin ratio (CAR) ( P =0.0224), and prognostic nutritional index (PNI) ( P =0.0078) as independent predictive factors. The Kaplan–Meier analysis showed that patients who met all of the following parameters avoided hospital death: NLR<30, PNI≥27.2, age<75 years, and perforation of the left colon. Conclusions: NLR, CAR, and PNI were superior to other IBPSs in predicting mortality of colorectal perforation. NLR, PNI, patient’s age, and sidedness of the perforation site may be useful parameters to identify subgroups in which a favorable prognosis can be expected. Funding Information: We thank the Kaibara Morikazu Medical Science Promotion Foundation, the Uehara Memorial Foundation, the Clinical Research Promotion Foundation and Fukuoka Public K. Kudou et al. Health Promotion Organization Cancer Research Fund for financial support. Declaration of Interests: Dr. Kensuke Kudou was supported by grants from the Kaibara Morikazu Medical Science Promotion Foundation in 2019, the Uehara Memorial Foundation in 2020, Grant of The Clinical Research Promotion Foundation in 2020 and Fukuoka Public Health Promotion Organization Cancer Research Fund in 2021. Drs. Tetsuya Kusumoto, Yuho Ebata, Sho Nambara, Yasuo Tsuda, Eiji Kusumoto, Rintaro Yoshida, Yoshihisa Sakaguchi, and Koji Ikejiri have no conflicts of interest or financial ties to disclose. Ethics Approval Statement: Permission to perform this study was provided by the Institutional Review Board of the National Kyushu Medical Center (20C033). The study conforms to the provisions of the Declaration of Helsinki (as revised in Fortaleza, Brazil, October 2013).
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Open AccessPrediction of Hospital Mortality after Colorectal Perforation Surgery from Inflammation-Based Prognostic Scores
Background: Inflammation-based prognostic scores (IBPSs) have prognostic value in cancer or cardiovascular disease patients. This study evaluated the prognostic value of IBPSs in colorectal perforation patients. Methods: Data of 97 patients who underwent surgery for colorectal perforation were reviewed. We calculated various IBPSs, and analyzed the relationship between IBPS and hospital mortality due to colorectal perforation. Results: Multivariate analyses of hospital mortality revealed neutrophil-lymphocyte ratio (NLR) ( P =0.0021), C-reactive protein/albumin ratio (CAR) ( P =0.0224), and prognostic nutritional index (PNI) ( P =0.0078) as independent predictive factors. The Kaplan–Meier analysis showed that patients who met all of the following parameters avoided hospital death: NLR<30, PNI≥27.2, age<75 years, and perforation of the left colon. Conclusions: NLR, CAR, and PNI were superior to other IBPSs in predicting mortality of colorectal perforation. NLR, PNI, patient’s age, and sidedness of the perforation site may be useful parameters to identify subgroups in which a favorable prognosis can be expected. Funding Information: We thank the Kaibara Morikazu Medical Science Promotion Foundation, the Uehara Memorial Foundation, the Clinical Research Promotion Foundation and Fukuoka Public K. Kudou et al. Health Promotion Organization Cancer Research Fund for financial support. Declaration of Interests: Dr. Kensuke Kudou was supported by grants from the Kaibara Morikazu Medical Science Promotion Foundation in 2019, the Uehara Memorial Foundation in 2020, Grant of The Clinical Research Promotion Foundation in 2020 and Fukuoka Public Health Promotion Organization Cancer Research Fund in 2021. Drs. Tetsuya Kusumoto, Yuho Ebata, Sho Nambara, Yasuo Tsuda, Eiji Kusumoto, Rintaro Yoshida, Yoshihisa Sakaguchi, and Koji Ikejiri have no conflicts of interest or financial ties to disclose. Ethics Approval Statement: Permission to perform this study was provided by the Institutional Review Board of the National Kyushu Medical Center (20C033). The study conforms to the provisions of the Declaration of Helsinki (as revised in Fortaleza, Brazil, October 2013).
- Open Access
- 17 July 2019
- Published by Springer Nature in Surgical Case Reports
- Vol. 5 (1) , 1-5
Refractory cutaneo-gastric conduit fistula after esophagectomy repaired by a pectoralis major muscle flap and split-thickness skin graft
Gastric conduit ulcer after esophagectomy is not uncommon. In cases where a gastric conduit ulcer penetrates the adjacent organs, it is difficult to select a suitable treatment strategy. The treatment depends on the adjacent organs penetrated. We report a case in which a reconstructed gastric conduit ulcer penetrated the precordial skin in a patient who had undergone esophagectomy due to spontaneous esophageal rupture 28 years previously. To treat the cutaneo-gastric conduit fistula, we resected the fistula, covered the site of anastomosis with a major pectoralis muscle flap, and applied a split-thickness skin graft to the skin defect. In cases of gastric conduit trouble in patients treated via the antesternal route, a major pectoralis muscle flap is useful because of its rich blood supply and easy mobilization. In addition, a split-thickness skin graft should be applied to the skin defect.
- 17 July 2019
- Published by Springer Nature in Surgical Case Reports
- Vol. 5 (1) , 1-5
Open AccessRefractory cutaneo-gastric conduit fistula after esophagectomy repaired by a pectoralis major muscle flap and split-thickness skin graft
Gastric conduit ulcer after esophagectomy is not uncommon. In cases where a gastric conduit ulcer penetrates the adjacent organs, it is difficult to select a suitable treatment strategy. The treatment depends on the adjacent organs penetrated. We report a case in which a reconstructed gastric conduit ulcer penetrated the precordial skin in a patient who had undergone esophagectomy due to spontaneous esophageal rupture 28 years previously. To treat the cutaneo-gastric conduit fistula, we resected the fistula, covered the site of anastomosis with a major pectoralis muscle flap, and applied a split-thickness skin graft to the skin defect. In cases of gastric conduit trouble in patients treated via the antesternal route, a major pectoralis muscle flap is useful because of its rich blood supply and easy mobilization. In addition, a split-thickness skin graft should be applied to the skin defect.
- 7 January 2015
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (8) , 2608-2614
Clinical Significance of SIP1 and E-cadherin in Patients with Esophageal Squamous Cell Carcinoma
Epithelial-mesenchymal transition (EMT), when epithelial cells convert to mesenchymal cells, influences cancer invasion and metastasis. Smad interacting protein 1 (SIP1) is an EMT trigger, which is inversely correlated with E-cadherin in some carcinomas. To elucidate the role of SIP1 in esophageal squamous cell carcinoma (ESCC), the status of EMT and the clinicopathological features were evaluated.
- 7 January 2015
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (8) , 2608-2614
Clinical Significance of SIP1 and E-cadherin in Patients with Esophageal Squamous Cell Carcinoma
Epithelial-mesenchymal transition (EMT), when epithelial cells convert to mesenchymal cells, influences cancer invasion and metastasis. Smad interacting protein 1 (SIP1) is an EMT trigger, which is inversely correlated with E-cadherin in some carcinomas. To elucidate the role of SIP1 in esophageal squamous cell carcinoma (ESCC), the status of EMT and the clinicopathological features were evaluated.